NCT04074460 2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4 Completed
Clinical Trials
9 trialsNCT01743560 2019-07-18
4EVERUK
Novartis
Phase 4 Completed
NCT03384511 2018-02-20
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
Shandong Cancer Hospital and Institute
Phase 4 Completed
NCT00882089 2018-01-25
Use of the Conturaâ„¢ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients
Cancer Center of Irvine
Phase 4 Completed
NCT00882596 2018-01-25
Use of the Conturaâ„¢ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients
Cancer Center of Irvine
Phase 4 Completed
NCT00434317 2017-02-23
Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases
Novartis
Phase 4 Completed
NCT01427400 2016-07-29
Botox
University of British Columbia
Phase 4 Unknown
NCT00616135 2011-05-17
RESTORE-2
Cytori Therapeutics
Phase 4 Completed
NCT00531973 2009-02-18
LITE
Catholic University, Italy
Phase 4 Unknown